middle.news
Memphasys Unveils $1.12M Entitlement Offer to Propel Felix™ Commercialisation
9:12am on Thursday 2nd of October, 2025 AEST
•
Healthcare
Read Story
Memphasys Unveils $1.12M Entitlement Offer to Propel Felix™ Commercialisation
9:12am on Thursday 2nd of October, 2025 AEST
Key Points
Pro-rata non-renounceable entitlement offer to raise up to $1.12 million
Free attaching options issued on a 1 for 4 basis with new shares
Placement of additional shares and options subject to shareholder approval
Funds primarily allocated to Felix™ system commercialisation and debt settlement
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Memphasys (ASX:MEM)
OPEN ARTICLE